Clinical Trials Directory

Trials / Completed

CompletedNCT01128062

Canthaxanthin Retinopathy: A Long-term Observation

Status
Completed
Phase
Study type
Observational
Enrollment
35 (actual)
Sponsor
University of Cologne · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Canthaxanthine is a naturally occurring carotenoid that has been a popular over-the-counter oral artificial tanning agent in Europe, Canada, and Australia since 1979. It is also used at low dosage as a food-colouring agent and as a therapeutic agent for photosensitivity disorders such as erythropoietic protoporphyria. Canthaxanthin retinopathy was first described in 1982 by Cortin et al. In Germany the office of the federal board of health refused the permit for oral tanning agents containing canthaxanthine in 1985. At that time the long-term course of the disease was not known. 25 years later the investigators did these long-term follow-up examinations.

Conditions

Timeline

Start date
1983-12-01
Primary completion
2009-12-01
Completion
2010-05-01
First posted
2010-05-21
Last updated
2010-05-21

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01128062. Inclusion in this directory is not an endorsement.